Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07863336 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ALSO-PERFORM Study. ALternating Stereotaxic Or PElvic Radiotherapy FOR Metachronic Metastatic Prostate Cancer

Study acronym: ALSO-PERFORM
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fields
  2. Study First Submitted
Outcome of metastasis directed therapy
Trial Details
NCT Number NCT07863336
Lead Sponsor Amsterdam UMC, location VUmc
Collaborators: Accord Healthcare, Inc.
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov